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Summary Expression of HLA antigens and 132-microglobulin was studied by immunoperoxidase staining of
frozen sections of 9 mucinous and 10 nonmucinous colorectal adenocarcinomas, 1 cloacogenic carcinoma, 12
colorectal adenomas and 4 samples of normal colorectal mucosa using monoclonal antibodies (MAbs).
Staining results were related to histopathological features. HLA Class I antigens were strongly expressed in
morphologically normal colorectal epithelium, in all adenomas tested and in all non-mucinous carcinomas. In
contrast, expression of HLA class I antigens by the majority of tumour cells was present in only 2 of the 9
mucinous carcinomas, whereas 2 of these mucinous carcinomas were completely negative. In the mucinous
carcinomas a striking scarcity of mononuclear inflammatory infiltrate, especially around the mucus
accumulations, was observed. HLA class II antigen expression was not detected in normal epithelium and
was only focally present in 1 of the 12 adenomas. In 6 out of the 20 carcinomas tested between 20% and
90% of the tumour cells were stained by MAbs against HLA class II antigens. Apart from the low
expression of HLA class I antigens in mucinous carcinomas no relationship was found between expression of
HLA antigens and histological features of the tumours. The relative poor prognosis of mucinous colorectal
carcinoma as reported in the literature may be associated with low expression of HLA class I antigens and
scant mononuclear inflammatory infiltrate, which may be a reflection of a weak immune response to the
tumour cells.
Immunohistochemical studies with monoclonal antibodies and of the mechanism(s) by which tumour cells escape
(MAbs) to HLA class I and class II antigens have clearly immune destruction.
shown that class I antigens are not expressed by all types of Since colorectal adenocarcinomas in general are considered
nucleated cells (Fleming et al., 1981; Harrist et al., 1983), and to evolve from adenomas, in addition a series of adenomas
that class II antigens have a broader tissue distribution than was investigated for the expression of HLA antigens.
originally postulated (Natali et al., 1981a). Furthermore,
malignant transformation may be associated with changes in
the HLA expression (Fleming et al., 1981; Thompson et al., Materials and methods
1982; Howe et al., 1981; Natali et al., 1981b; Ruiter et al.,
1982). Surgically and endoscopically removed tissues
In colorectal cancer loss of expression of HLA class I The material consisted of 12 adenomas and 20 carcinomas (9
antigens and de novo expression of HLA class II antigens has mucinous and 10 nonmucinous adenocarcinomas and 1
been demonstated (Daar et al., 1982; Csiba et al., 1984; cloao and carcinomas and 1
Momburg et al-, 1986). A positive correlation between the cloacogenic carcinoma, basaloid type) of colon and rectum. degree
etanul.,e1986ar positrtio colorelation betweenomas Representative samples from the tumours removed at degree of mononuclear infiltration in colorectal carcinomas, endoscopy and laparotomy were snap frozen in OCT corn- consisting mainly of T-cells (Csiba et al., 1984; Umpleby et endoscopy and ot w es Laborozen Elkhardm al., 1985) and prognosis has been found (Watt & House, pound (Ames Co., Division of Miles Laboratories, Elkhard)
1978; Spratt & Spjut, 1967; Nacopoulou et al., 1981; and stored at -70°C. The main portion was processed for 1978; Spratt & Spjut, 1967; Nacopouloueta.191 routine histological examination. In addition three samples Svennevig et al., 1984). It has been suggested that tumour- of grossly normal appearing colonic mucosa and one of infiltrating lymphocytes inhibit tumour growth by response n ormal appearing colonap froze and ored
to tumour antigens associated with HLA class I and class II ormal appearing anal mucosa were snap frozen and stored
antigens (Umpleby et al., 1985). Scarcity or virtual absence at-r70nCo At least three tissue blocks of each of the
of inflammatory infiltrate is frequently encountered around carcinomas were included for histopathological examination.
mucus accumulation of mucinous colorectal carcinomas, The histopathological diagnosis was made on paraffin mucus accumulation of mucinous colorectal carcinomas, sections stained with H & E. Nine carcinomas of which at which bear a worse prognosis than the nonmucinous carci-
nomas (Wolfman et al., 1957; Symonds & Vickery, 1976; least 60% of the estimated tumour volume consisted of the noma (Wlfma etal.,195; Syond & Vckey, 176; mucinous variety were classified as mucinous carcinomas Almagro et al., 1983). Therefore, in view of the role played acing ty and Viked as Two of these by HLA class II antigens in cell-cell interactions required to ccording to Symonds and Vickery (1976). Two of these
generate immune responses (Thorsby et al., 1976) and by mucinous carcinomas were purely intracellular mucinous or
HLA class I antigens in the interaction between target cells signet-ring carcinomas. The adenomas were of all t d
and cytotoxic T-cells (McMichael, 1980) we investigated a grades of dysplasia.
series of mucinous and non-mucinous colorectal carcinomas
for expression of HLA antigens in relation to the degree of Monoclonal antibodies
mononuclear infiltrate. Characterization of the relationship
between changes in the HLA phenotype and transformation The MAb CR1 recognizing a monomorphic determinant of
of cells may contribute to our understanding of the inter- HLA-A,B,C antigens was prepared and characterized as
actions of tumour cells with the immune system of the host described elsewhere (Pellegrino et al., 1982). The MAb
- ~~~~~~~~~W6/32 to a framework determinant of HLA-A,B,C antigens
(Barnstable et al., 1978; Parham et al., 1979) is secreted by a
Correspondence: D.J. Ruiter at his present address: Department of hybridoma obtained from Dr P. Parham (Stanford
Pathology, University of Nijmegen, Geert Grooteplein Zuid 24, 6525 University Medical School, Palo Alto, California, USA).
GA Nijmegen, The Netherlands. An additional anti HLA class I MAb was purchased from
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Federal Republic of Germany (anti-HLA MAb BRL). A peripheral staining surrounding the mucus. No staining was
MAb to Beta-2 microglobulin (f21i1) was purchased from detected with the anti HLA class II MAbs Q5/13 and BRL.
OLAC, Blockthorn, Bicester, Oxon, UK. This antibody will The basal three quarters of the squamous epithelium of the
be referred to as anti f2m MAb OLAC. The MAb Q5/13 histologically normal anal mucosa were brightly stained by
recognizing a monomorphic determinant of HLA class II the anti HLA class I MAbs CR1, W6/32 and BRL and the
antigens was developed and characterized as described else- anti f2m MAb OLAC.
where (Quaranta et al., 1980). An additional anti HLA class Only dendritic cells were stained by the anti HLA class II
II MAb referred to as anti HLA class II MAb BRL, an anti MAbs Q5/13 and BRL.
HLA-DR antibody, was purchased from Bethesda Research The majority of tumour cells in all the adenomas and in
Laboratories, Inc. Control mouse ascites was purchased most of the adenocarcinomas tested showed marked staining
from Bethesda Research Laboratories Inc. with the anti HLA class I and anti fl2m MAbs (Tables I and
II; Figure 1). In most of the lesions tested the percentage of
Immunoperoxidase studies tumour cells stained and the intensity of staining with the
Four-micron thick frozen sections were air-dried and fixed in anti f2M MAb OLAC were similar or slightly lower than
acetone for 10mm. Sections were then incubated for 60.mm those with the anti HLA class I MAbs CRA, W6/32 and
at room temperature with a MAb and for 30mi with a BRL. In normal mucosa adjacent to carcinomas the
rabbit anti-mouse Ig-horse radish peroxidase conjugate percentage of epithelial cells stained by the anti class I MHC
(Dako Immunoglobulins, Copenhagen, Denmark). Between and anti . 32m MAbs was similar or higher than in
each conjugation, sections were washed three times with carcinomas. The staining pattern of adenomas and carci-
PBS, pH 7.4. Staining was achieved by incubation of
nomas was partly diffuse and partly patchy, i.e. adjacent to
sections in an acetate buffer solution (pH 5.0) that contained strikingly positive areas there were also areas which did not
3-amino-9-ethyl-carbazole (Aldrich Chemical Co., Inc., show any reaction at all. This was observed in the centre as
Milwaukee, Wis., USA), dimethylformamide and hydrogn 'well as the border of the section. There were no apparent
Milwauke., i.e, sA),s dimethyfm id and hydro,g architectural or cytological differences between these areas.
pounteroxi. .Te in were washed,yin andcovetate p ber Seven of the 9 mucinous carcinomas (including two signet-
cit auaounte Mayer'sBHChemiatoylin nd. covliedUK) ring cell carcinomas) tested were less reactive than the
wiconthramounth
(Gur, BDH Cheicals
Ltd. .ple, U).' adenomas and the other types of adenocarcinomas with the
As controls thuemonclonal atBodywithasireplacd
by P three MAbs to the HLA class I antigens (Table I; Figure 2).
or controlmouseascites(BRL), with a simir pOn the other hand no difference between the nonmucinous
concentration as the MVAb SOlUtiOnl. Thncenumbern ofstad eiteia. cl w e adenocarcinomas and the adenomas was found both in the Thepnden by two erversan expressed asea intensity and patter of staining. The mononuclear infiltrate
independently by two observers and expressed as a
in th uioscrioa.wssac n oeie
percentage of the total number of tumour cells in each
section. The estimations of the different observers were
always in the same range. The mononuclear inflammatory . eR.
infiltrate was classified according to the density of the
stromal infiltration adjacent to the carcinomas and was
graded as follows: -: no infiltrate; ±: scarce; +: present as
perivascular aggregates; 2+: dense band-like aggregates. _
Northern blotting studies
Total RNA from frozen tumour specimens (0.2g) was
isolated by grinding the tissue in 2ml of 6 M urea, 3 M LiCl
for I min at 0°C with an ultraturrax mixer. The mixture was
left overnight and after centrifugation for 30min at
10,000rpm in a Sorvall SS34 rotor, the precipitate was
dissolved in 3ml of 1OmM Tris-HCI (pH=7.8), 0.5% SDS at
room temperature. After phenol extraction and ethanol u
precipitation according to standard procedures (Maniatis et
al., 1982), the RNA pellet was dissolved in sample buffer Figure 1 Marked expression of HLA class I antigens in a non-
and the RNA concentration was estimated by OD260 mucinous colonic carcinoma (cryostat section, x 400, haema-
measurement of an aliquot in TE buffer and subsequent toxylin counterstain).
electrophoresis on a TBE gel (Maniatis et al., 1982). RNA
concentrations were adjusted according to the EtBr staining
of the ribosomal bands in this gel and for blotting, equal -* i (
amounts of RNA in sample buffer were loaded on an X
agarose-formaldehyde gel. Northern blotting was performed *
according to standard procedures (Maniatis et al., 1982). The ^,
filter was hybridized to a HLA-B7 probe (Sood et al., 1981)
labelled with (a-32P)-dCTP by the Klenou enzyme after
priming with random hexanucleotides (Feinberg &
Vogelstein, 1984), washed with 2x_SSC at 50°C and S
Results - s ^ * 4 +~
About~~~~~~~~~ ~ ~ ~ ~ 90 of. eptela cells in th hitlgial noma -i" -t
.'-.
F
colonicmucosa were stained bytntheathi H°LAiclass Ioma MAbs PI6<J'. 8 ¾> R
CR1I, W6/32 and BRL and -~80% by the anti 1B½m MAb Figure 2 Lack of expression of HLA class I antigens in a
OLAC. The brightest staining was seen at the luminal side mucinous colonic carcinoma. Note the marked staining of the
of the mucosa and occurred as a diffuse cytoplasmic and stromal septa (cryostat section, x400, haematoxylin counter-
peripheral pattern. Goblet cells in crypts showed only stain).LOW HLA CLASS I EXPRESSION IN MUCINOUS COLORECTAL CARCINOMAS 127
Table I Expression of HLA class I and II antigens and #2f-microglobulin, intensity of mononuclear infiltrate,
histologcal type and degree ofdifferentiation in 20 colorectal carcinomas with Dukes' stage and follow-up data
HLA class I
and#23-micro- IntensitY of
Case Histological Dukes' globulin HLA class II mononuclear Follow-up Current
number diagnosis' stage %C % infdtrated period statusc
1 PDA C 90 90 + + 2 yrs AWD
2 MDA D 100 0 + + 6 months DOD
3 WDA A 90 5 + + 4 yrs AND
4 MDA A 100 5 + 0 DOC'
5 PDA B 80 5 + + I yr AND
6 MDA C 70 0 ++ 4yrs AND
7 MDA C 90 0 + 3 yrs AND
8 WDA B 90 5 + 3 yrs AND
9 MDA B 80 5 + 32yrs AND
10 PDA B 100 0 + 9 months DOC'
11 PDA, mucinous C 90 20 + 1yrs AWD
12 MDA. mucinous B 10 5 + 4 yrs AND
13 PDA, mucinousb C 40 0 + 3- yrs AWD
14 MDA. mucinous B 40 0 - 3 yrs AND
15 MDA. mucinous A 0 0 - 4 yrs AND
16 MDA, mucinous C 10 60 - 2 yrs AND
17 MDA, mucinous A 90 20 + 20 yrs AND
18 PDA, mucinous B 0 40 + lost for not known
follow-up
19 PDA mucinousb C 0 0 - 6 months DOD
20 Cloacogenic
carcinoma NA" 90 40 + +
aWDA=well differentiated adenocarcinoma, MDA=moderately differentiated adenocarcinoma, PDA =poorly
differentiated adenocarcinoma; 'Signet-ring cell carcinoma: cPercentage of stained tumour cells; d-: absent; ±:
scarce. +: present in perivascular aggregates. + +: dense bandlike aggregates; 'AWD=alive with disease.
AND=alive, no disease. DOD=died of disease. DOC=died of other causes; fDuring post-operative period; "At
autopsy no metastases were found; "Not Applicable.
Table II Expression of HLA antigens and #f-microglobulin on frozen
sections of colorectal adenomas with size and histological features of the
adenomas
HLA class I
and13,-micro- Si-e of
Case globulin HLA class II lesion Tipe of Degree of
no. %a§ % (cm) aidnoma' displasta
I 90 0 1.5 T miild
2 100 0 1.5 T mild
3 90 0 1.2 T moderate
4 80 0 2.1 T moderate
5 100 0 1.5 TV mild
6 100 0 1.2 T mild
7 100 0 0.9 T moderate
8 90 0 1.1 T mild
9 90 0 3.5 TV severe
10 100 0 2.5 V moderate
11 70 0 1.2 TV mild
12 90 5 2.5 TV severe
'a%O: percentage of stained tumour cells; 'T =tubular adenoma;
TV =tubulovillous adenoma; V =villous adenoma.
absent (Table I) espeaally around areas of extensive mucus or barely stained by the anti HLA class II MAbs Q5- 13 and
accumulations. BRL except cases 16 and 19 (Table I).
The anti HLA class II MAbs Q5/13 and BRL produced Incubation of the cloacogenic carcinoma with the anti
bright staining of the majority of tumour cells in two HLA class II MAbs Q5113 and BRL resulted in a bright
adenocarcinomas (cases 1 and 16. Table I) and in a minority staining, predominantly at the periphery of tumour cell nests.
Of the tumour cells in 11 other adenocarcinomas. Three In addition in 5 cases, 2 mucinous and 3 non-mucinous
adenocarcinomas showed bright staining of adjacent carcinomas we isolated m-RNA from the tumour tissue and
dysplastic mucosa. In the remaining adenocarcinomas and in undertook Northern blotting analysis using a cDNA probe
all adenomas except one no staining was detected or only specific for HLA class I. As can be seen in Figure 3 all three
sporadic cells were stained by the anti HLA class II MAbs non-mucinous colorectal carcinomas showed a highl
Q5/13 and BRL. Only one adenoma (case 12, Table II) expression of HLA class I m-RNA (lanes 6-8) while one of
showed staining of some tubules. Adenocarcinomas with low two mucinous carcinomas tested showed a reduced
or no expression of HLA class I antigens in general were not expression (lane 4).
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Figure 3 Autoradiogram of blot hybridization analysis of RNA
with a DNA probe (HLA-B7) specific for HLA class I. RNA
was isolated from: (1) Melanoma cell line Mel 57 (high
expression of HLA class I); (2) Melanoma cell line 136-2 (low
expression of HLA class I); (3) Striated muscle; (4) case no. 19;
(5) case no. 16; (6) case no. 4; (7) case no. 6; (8) case no. 8.
Discussion
The present study shows that HLA class I antigens and f2
microglobulin are expressed by morphologically normal
colorectal epithelium, by all colorectal adenomas examined
and only by varying proportions of tumour cells in
colorectal adenocarcinomas. Low expression, or absence of
HLA class I antigens and #2-microglobulins was nearly
always observed in the mucinous carcinomas.
Several mechanisms may account for these findings. These
include pretranscriptional events such as mutations that
cause deletions of the gene(s) coding for the heavy chain of
HLA class I antigens and/or #2m. The latter is required for
the expression of HLA class I antigens (Krangel et al., 1981;
Ploegh et al., 1979). In addition the low expression of HLA
class I antigens may be due to a posttranscriptional event
such as masking by autoantibodies, sialic acid, mucus or to
blocking of (HLA) anti class I antibodies by antigens shed
into mucus (Black, 1980). The influence of masking by
mucus could not be demonstrated, since treatment of the
tissue sections with periodate did not result in increased
staining for HLA class I antigens. In preliminary Northern
blotting experiments using a DNA probe specific for HLA
class I mRNA of 5 carcinomas of which enough frozen
tissue was available (Figure 3) we found that in one of the
two mucinous carcinomas with low or absent HLA class I
expression a low level of mRNA coding for HLA class I
antigens was present. For the other mucinous lesion
however, as for the 3 non-mucinous carcinomas tested
evidence for a high level of transcription of mRNA for HLA
class I antigens could be demonstrated. This indicates that
low expression of HLA class I antigens may be attributed to
different mechanisms. Whatever the mechanism, lack of
HLA class I and f2m antigens on malignant cells is not
unique to colorectal adenocarcinoma since it has been
described for tumour cells in long term culture as well as for
surgically removed lesions of various embryological origin
(Fleming et al., 1981; Weiss et al., 1981; Mauduit et al.,
1983; Natali et al., 1983a,b; Bhan & Desmarais, 1983). In
view of the association between changes of HLA class I
antigens and fl2m as well as of H-2 antigens, the murine
counterpart of HLA class I antigens, and progression of
malignancy in various tumours (Weiss et al., 1981; Mauduit
et al., 1983; De Baetselier et al., 1980; Sanderson & Beverley,
1983), it is noteworthy that signet-ring cell carcinomas and
other mucinous colorectal carcinomas have a worse prog-
nosis than non-mucinous carcinomas (Wolfman et al., 1957;
Symonds & Vickery, 1976; Almagro, 1983).
The absence or low expression of HLA class I antigens on
mucinous colorectal carcinoma may give an explanation for
its relatively poor prognosis, because it may provide tumour
cells with a mechanism with which to escape a cellular
immune response (Bernards et al., 1983; Schrier et al., 1983).
In this respect it is noteworthy that we, like Symonds and
Vickery (1976), observed a striking scarcity of mononuclear
inflammatory infiltrate adjacent to the mucus accumulations
in this type of carcinoma. Further analysis of the mono-
nuclear cell infiltrate in colorectal carcinomas has shown a
predominance of T-lymphocytes (Csiba et al., 1984; Umpleby
et al., 1985) as has been reported for other tumours (Ruiter
et al., 1982; Bahn and Desmarais, 1983; Kabawat et al.,
1983) which is suggestive of an important role of the cell-
mediated immune response to carcinomas. However, as yet,
no clear relationship between the class of HLA antigens
expressed on the tumour cells and a particular subset of
adjacent T-lymphocytes could be demonstrated (Csiba et al.,
1984, Umpleby et al., 1985).
In accordance with other reports (Daar et al., 1982; Csiba
et al., 1984) also concerning relatively small series ofcolorectal
carcinomas, but in contrast to the observation of Momburg
et al. (1986) on a large series of colorectal carcinomas, no
obvious correlation between degree of differentiation and
expression of HLA class I antigens could be demonstrated.
In the present series of 19 adenocarcinomas no correlation
could be demonstrated between the expression of HLA class
I antigens, the degree of mononuclear inflammatory infiltrate
or the type of adenocarcinoma (i.e. mucinous or non-
mucinous), and the Dukes stage or the outcome of the
disease. However, the present series is small and the follow-
up period is relatively short (see Table I).
Detection of substantial quantities of HLA class II
antigens on 6 out of the 20 colorectal carcinomas tested is in
agreement with the information available in the literature,
although in our study the appearance of HLA class II
antigens has a frequency lower than that found by
Thompson et al. (1982), Daar et al. (1982), and Rognum et
al. (1983) but is comparable with that of Csiba et al. (1984).
This discrepancy may reflect differences in the sensitivity of
the assay system, in the specificity and affinity of the
antibodies and/or in the characteristics of the tumour
analyzed. Like Daar et al. (1982) and Momburg et al.
(1986), but in contrast with Rognum et al. (1983) we have
not found any relationship between the appearance of HLA
class II antigens and the degree of differentiation or Dukes'
stage. In colonic cells of epithelial lineage the appearance of
HLA class II antigens does not appear to be restricted to
those which have undergone overt malignant transformation
since these antigens were also detected in dysplastic
epithelium surrounding carcinomas. Furthermore, expression
of HLA class II antigens has been demonstrated in colonic
epithelium involved in inflammatory bowel diseases (Selby et
al., 1983). The association of a low expression of HLA class
I antigens with a relative high expression of HLA class IILOW HLA CLASS I EXPRESSION IN MUCINOUS COLORECTAL CARCINOMAS 129
antigens in two mucinous carcinomas (Cases 16 and 18,
Table I) is remarkable since in normal tissues (Harrist et al.,
1983; Natali et al., 1984) and other malignant tumours, e.g.
melanoma (Ruiter et al., 1984) expression of HLA class II
antigens largely seems to be restricted to cells that also
express HLA class I antigens. In the large series of colorectal
carcinomas studied by Momburg et al. (1986) loss of HLA
class I expression and de novo expression of HLA class II
antigens were statistically independent.
The 12 colorectal adenomas tested showed HLA class I anti-
gen expression in similar amounts to that of morphologi-
cally normal colorectal mucosa. Only one of the adenomas
showed focal expression of HLA class II antigen, which is in
accordance with the data of other investigators (Thompson
et al., 1982; Csiba et al., 1984). Interestingly, using DNA
flow cytometry measurements of 5 of the investigated
adenomas only this adenoma had shown aneuploidy (DNA
indexes 1.00, 1.17 and 1.84) (Van den Ingh et al., 1985).
Since aneuploidy is strongly associated with malignancy
(Barlogie et al., 1983) ploidy aberration in this case of
adenoma suggests early malignant transformation, which
may be related to the focal expression of HLA class II
antigen.
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